HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Koichi Izumikawa Selected Research

liposomal amphotericin B

12/2022Association between fluid infusions and the recovery from acute kidney injury in patients administered liposomal amphotericin B: a nationwide observational study.
9/2022Comparison of liposomal amphotericin B alone and in combination with flucytosine in the treatment of non-HIV Cryptococcal meningitis: A nationwide observational study.
10/2021Efficacy of early administration of liposomal amphotericin B in patients with septic shock: A nationwide observational study.
3/2021The clinical usage of liposomal amphotericin B in patients receiving renal replacement therapy in Japan: a nationwide observational study.
1/2021Association between potassium supplementation and the occurrence of acute kidney injury in patients with hypokalemia administered liposomal amphotericin B: a nationwide observational study.
1/2020Factor analysis of acute kidney injury in patients administered liposomal amphotericin B in a real-world clinical setting in Japan.
1/2018Primary Oral Mucormycosis Due to Rhizopus microsporus after Allogeneic Stem Cell Transplantation.
7/2015International expert opinion on the management of infection caused by azole-resistant Aspergillus fumigatus.
2/2014Efficacy of aerosolized liposomal amphotericin B against murine invasive pulmonary mucormycosis.
8/2009Efficacy of combination antifungal therapy with intraperitoneally administered micafungin and aerosolized liposomal amphotericin B against murine invasive pulmonary aspergillosis.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Koichi Izumikawa Research Topics

Disease

50Pneumonia (Pneumonitis)
06/2022 - 07/2002
49Infections
06/2021 - 05/2002
13Pulmonary Aspergillosis
04/2022 - 05/2007
9Human Influenza (Influenza)
02/2021 - 01/2008
9Bacterial Pneumonia
10/2020 - 01/2007
8Cryptococcosis
04/2019 - 05/2008
8Pneumococcal Pneumonia
01/2019 - 03/2007
8Respiratory Tract Infections (Respiratory Tract Infection)
09/2018 - 12/2008
7COVID-19
08/2022 - 01/2021
6Candidiasis (Moniliasis)
08/2021 - 02/2006
6Aspergillosis
06/2021 - 01/2008
6Fever (Fevers)
01/2020 - 04/2007
6Abscess
09/2019 - 10/2006
5Neoplasms (Cancer)
01/2022 - 01/2007
5Disease Progression
08/2021 - 05/2012
5Sepsis (Septicemia)
01/2021 - 08/2000
5Communicable Diseases (Infectious Diseases)
01/2021 - 06/2008
5Invasive Candidiasis
12/2020 - 12/2008
5Chronic Obstructive Pulmonary Disease (COPD)
12/2020 - 05/2009
5Hemorrhage
04/2020 - 03/2007
5Healthcare-Associated Pneumonia
02/2020 - 02/2009
5Interstitial Lung Diseases (Interstitial Lung Disease)
01/2020 - 10/2006
5Bacteremia
09/2019 - 01/2015
5Liver Diseases (Liver Disease)
04/2019 - 05/2002
5Inflammation (Inflammations)
09/2016 - 09/2008
4Pleural Effusion (Pleural Effusions)
01/2022 - 01/2008
4Mycoses (Diseases, Fungus)
03/2021 - 01/2008
4Respiratory Insufficiency (Respiratory Failure)
12/2020 - 07/2010
4Pneumococcal Infections
12/2020 - 01/2009
4Bronchiectasis
01/2017 - 02/2007
4Ventilator-Associated Pneumonia
01/2017 - 08/2012
4Dyspnea (Shortness of Breath)
01/2017 - 09/2008
4Coinfection
09/2014 - 01/2008
4Cystic Fibrosis (Mucoviscidosis)
10/2011 - 01/2009
3Acute Kidney Injury (Acute Renal Failure)
12/2022 - 01/2020
3Aspiration Pneumonia
01/2022 - 04/2013
3Shock
10/2021 - 01/2021
3Septic Shock (Toxic Shock Syndrome)
10/2021 - 01/2016
3Respiratory Tract Diseases (Respiratory Tract Disease)
01/2021 - 05/2011
3Ulcer
01/2019 - 01/2014
3Fibrosis (Cirrhosis)
01/2018 - 09/2008
3Body Weight (Weight, Body)
01/2017 - 05/2008
3Pseudomonas Infections
01/2017 - 01/2010
3Hypoxia (Hypoxemia)
03/2014 - 09/2007
3Diabetes Mellitus
01/2014 - 01/2007
2Myocarditis (Carditis)
08/2022 - 01/2014
2Asthma (Bronchial Asthma)
04/2022 - 12/2009
2Granuloma
08/2021 - 09/2008
2Hypersensitivity (Allergy)
04/2021 - 01/2016

Drug/Important Bio-Agent (IBA)

37Anti-Bacterial Agents (Antibiotics)IBA
01/2022 - 05/2002
19Pharmaceutical PreparationsIBA
12/2022 - 05/2004
14MacrolidesIBA
01/2022 - 04/2005
13AntigensIBA
04/2021 - 03/2003
12liposomal amphotericin BFDA Link
12/2022 - 05/2008
12Micafungin (FK463)FDA Link
10/2020 - 05/2007
9SteroidsIBA
08/2022 - 09/2007
8Adrenal Cortex Hormones (Corticosteroids)IBA
08/2021 - 10/2006
8AzolesIBA
06/2021 - 01/2008
8Clarithromycin (Biaxin)FDA LinkGeneric
01/2021 - 02/2007
8VancomycinFDA LinkGeneric
02/2020 - 09/2006
7CytokinesIBA
04/2022 - 08/2000
6QuinolonesIBA
11/2019 - 06/2014
5Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
04/2022 - 01/2012
5C-Reactive ProteinIBA
01/2022 - 06/2008
5Anti-Infective Agents (Microbicides)IBA
01/2021 - 07/2002
5Linezolid (Zyvox)FDA Link
02/2020 - 11/2009
5Voriconazole (Vfend)FDA LinkGeneric
01/2020 - 09/2008
5Fluconazole (Zonal)FDA LinkGeneric
01/2017 - 05/2004
5FluoroquinolonesIBA
01/2017 - 01/2006
5Azithromycin (Zithromax)FDA LinkGeneric
01/2014 - 03/2008
5Ciprofloxacin (Cipro)FDA LinkGeneric
07/2013 - 03/2003
4RNA (Ribonucleic Acid)IBA
08/2022 - 01/2019
4Oxygen (Dioxygen)IBA
04/2021 - 01/2010
4EnzymesIBA
02/2021 - 01/2014
4EchinocandinsIBA
10/2020 - 11/2014
4Carbapenems (Carbapenem Antibiotics)IBA
04/2019 - 06/2008
4Oseltamivir (Tamiflu)FDA Link
01/2017 - 01/2008
4Biological ProductsIBA
01/2016 - 02/2014
4sivelestatIBA
10/2010 - 03/2007
4Ampicillin (Omnipen)FDA LinkGeneric
03/2009 - 01/2006
3Flucytosine (Ancobon)FDA Link
09/2022 - 09/2008
3Rifampin (Rifampicin)FDA LinkGeneric
04/2021 - 01/2008
3Biomarkers (Surrogate Marker)IBA
01/2021 - 09/2017
3Antifungal AgentsIBA
10/2020 - 01/2016
3Itraconazole (Sporanox)FDA LinkGeneric
01/2020 - 01/2010
3garenoxacinIBA
11/2019 - 09/2014
3DNA (Deoxyribonucleic Acid)IBA
02/2017 - 09/2008
3Meropenem (Merrem)FDA LinkGeneric
01/2017 - 12/2008
3Amphotericin B (Amphotericin)FDA LinkGeneric
01/2017 - 05/2008
3biapenem (L 627)IBA
09/2013 - 01/2008
2Proteins (Proteins, Gene)FDA Link
08/2022 - 01/2019
2SARS-CoV-2 spike proteinIBA
08/2022 - 01/2021
2VaccinesIBA
08/2022 - 01/2016
2Sulfur Compounds (Compounds, Sulfur)IBA
01/2022 - 05/2020
2Antiviral Agents (Antivirals)IBA
04/2021 - 01/2015

Therapy/Procedure

44Therapeutics
08/2022 - 05/2002
4Drug Therapy (Chemotherapy)
08/2021 - 01/2008
4Central Venous Catheters
02/2021 - 10/2006
3Duration of Therapy
02/2021 - 10/2011
3Aftercare (After-Treatment)
04/2019 - 02/2010